Genetics, commodification, and social justice in the globalization era

Area of Science:

• Biotechnology Law
• Bioethics
• Intellectual Property Law

Background:

• The increasing commercialization of biotechnology, particularly by transnational pharmaceutical companies, raises significant ethical and social concerns.
• Existing frameworks may inadequately address the implications of gene patenting on distributive justice and human rights.

Purpose of the Study:

• To critically analyze the impact of gene patenting on distributive justice, human rights, and access to essential goods for marginalized populations.
• To advocate for enhanced and internationally coordinated regulation of gene patenting.

Main Methods:

• The study employs a pragmatic argumentation style, drawing on legal and ethical scholarship, including the work of Margaret Jane Radin.
• It emphasizes evidence-based persuasion regarding the effects of profit-driven control in genetic research.

Main Results:

• Current gene patenting practices are deemed excessive and detrimental to equitable access and human rights.
• There is a compelling need for more stringent regulation of gene patenting.

Conclusions:

• Gene patenting requires robust international regulation, prioritizing solidarity and the common good.
• A pragmatic, evidence-based approach is crucial for effective policy reform in biotechnology intellectual property.